The 10x Tech Boom Portfolio

The “frenzy phase” of our current tech stock boom is a rising tide set to lift a lot of ships. There will be many companies involved in solving the critical problems faced by the modern economy – and transforming entire industries overnight. 

This is a once-in-a-generation wealth creation event. We haven’t seen anything like it since the 1990s dot-com boom. 

When we combine the $18 trillion in cash held by Americans that’s ready to flood into the market… the inevitable intervention of the Federal Reserve… and the fact that the country is currently led by the most pro-stock-market president in history… we are looking at a perfect storm set to send tech stocks into the stratosphere… 

This is the exact moment Warren Buffett, Jeff Bezos, and Jamie Dimon – alongside another 16 prolific billionaires – rapidly positioned themselves for in 2024. And it’s worth pausing to understand why that matters to you. 

These aren’t gamblers chasing a hot tip. These are the most battle-tested investors alive. They’ve lived through the dot-com crash, the 2008 financial crisis, and the COVID collapse. They don’t move together by accident – and in 2024, 19 of them moved in the same direction at the same time. 

When the smartest money in the world bets big on a moment like this, there’s really only one question worth asking: Are you going to be positioned when it hits? 

The winners in this final phase will likely be companies you’ve never heard of.  

For instance, the three companies in this report are relatively unknown. Yet they are positioned to absolutely explode in the coming months and years.  

They also satisfy many of my key triggers for millionaire-maker potential.  

Here’s a quick rundown… 

1. Three consecutive quarters of sales growth
2. Increased earnings per share (EPS) year over year
3. A relative strength index (RSI) over 40 during the last 14 trading days
4. Insider buying
5. Innovative and disruptive products or services.

As you’ll see, each of these companies is shaking up its industry in profound ways. Each has the potential to soar 1,000% over the next 12 months. And each has the potential to make you millions – just like Netflix, Apple, and Nvidia made their earliest investors… 

Navigating the Future: NextNav’s 3D GPS Revolution 

Up first is a company revolutionizing a service that has become totally ubiquitous in the modern world: GPS. 

Traditional GPS uses satellites to show your location on a map, give you road directions, or help you find a location you’re looking for. But it has a critical limitation: verticality.  

That is, traditional GPS can display your location only on the x- and y-axes. It’s two-dimensional. 

McLean, Virginia-based NextNav (Nasdaq: NN) is changing that. Its GPS, dubbed TerraPoiNT, doesn’t use satellites at all. Instead, it uses the terrestrial 5G network to build a 3D map that overcomes GPS’ core limitations – including its failure to work indoors and its tendency to malfunction in dense urban areas. 

Consider what that means in a real-world emergency. If someone has a heart attack on the 20th floor of a skyscraper, seconds could mean the difference between life and death. With NextNav, paramedics don’t search floor by floor – they go directly to the caller’s exact location. That’s the power of true 3D positioning. 

There’s also a national security dimension. A one-day outage of the satellite GPS network would generate an economic loss of $1.6 billion. NextNav’s terrestrial backup network can reduce that figure by $663 million – making it not just commercially valuable, but strategically essential. 

NextNav’s network is now live in 4,400 cities across the United States. It checks every box I look for in a millionaire-maker stock – and its financial performance backs it up… 

The company’s revenue has been growing by leaps and bounds over the last seven quarters, more than double what I look for. In the last three quarters, Q3 2024, Q4 2024, and Q1 2025, revenue has grown by 56.5%, 58.6%, and 47.1%, respectively, year over year. This easily satisfies the revenue growth criterion. 

Financial Performance That Screams “Millionaire-Maker” 

Revenue has been growing by leaps and bounds over the last seven consecutive quarters – more than double the pace I look for. In Q3 2024, Q4 2024, and Q1 2025, revenue grew 56.5%, 58.6%, and 47.1% year over year, respectively. Trigger one: ✅. 

EPS surged 57% year over year in Q1 2025, the most recently reported quarter. Trigger two: ✅. 

NextNav’s RSI is sitting at 70.39 at the time of writing. A reading of 70 or above signals strong buying pressure – but even if momentum cools from here, this stock fits my criteria as long as the RSI stays above 40. Trigger three: ✅. 

Finally, insider buying. It’s the ultimate vote of confidence when the people who know a company best put their own money on the line. Neil Subin, a director, bought 225,000 shares in August 2024 and hasn’t sold a single one since. That’s the kind of conviction I want to see. Trigger four: ✅. 

NextNav meets every standard I look for – and it’s still trading at bargain-basement prices. Buy in before the rest of the market catches on… 

Recommendation: Buy NextNav (Nasdaq: NN) at market. Set a 25% trailing stop to protect your principal and your profits.

AI at the Doctor’s Office: Phreesia’s Healthcare Data Engine 

One of the most predictable long-term tech booms isn’t happening in Silicon Valley – it’s happening in your doctor’s waiting room. An aging population, relentlessly rising medical costs, and a crushing paperwork burden are forcing hospitals, clinics, and drugmakers to embrace automation and AI at a breakneck pace. 

Wilmington, Delaware-based Phreesia (NYSE: PHR) sits right at the crossroads of this transformation.  

The company is a leader in patient-intake automation and digital front-door tools for healthcare providers – online registration, insurance verification, appointment reminders, point-of-care payments, and flexible payment plans. It handles the unglamorous but mission-critical work that every healthcare provider needs done, and it does it better than anyone else. 

The scale here is staggering for a company of its size. Phreesia serves more than 4,400 healthcare clients – from specialty practices to full hospital networks – and its client base has tripled since going public in 2019.  

Every one of the top 10 global pharmaceutical companies uses Phreesia to deliver targeted, compliant advertising and patient education at the point of care. In the last year alone, the platform facilitated over 170 million patient visits. That’s roughly 1 in 7 doctor’s visits in the United States. 

That kind of embedded scale – inside a sub-$2 billion company – is exactly what a millionaire-maker looks like… 

Phreesia Hits All My Triggers 

Starting with revenue growth… 

Phreesia has been putting up exceptional numbers. Sales have been growing at a strong double-digit clip, with Q4 fiscal 2025 revenue coming in at roughly $109.7 million and management forecasting higher revenue per client as new products roll out. Trigger one: ✅. 

On earnings power… 

After years of heavy platform investment, Phreesia is entering a margin-expansion phase. EPS is projected to climb from roughly $1.00 to nearly $1.60 as operating leverage kicks in. The inflection is happening now. Trigger two: ✅. 

On RSI… 

Phreesia’s RSI profile has begun triggering fresh buy signals in 2026 – strong momentum building without being dangerously overbought. Trigger three: ✅. 

And the insiders agree… 

Phreesia has authorized a 2.5 million-share repurchase program – a direct signal that management believes the stock is undervalued at current prices. Large institutional holders have been building sizable positions. That combination of buybacks and strong long-term ownership alignment is a powerful endorsement of what’s coming. Trigger four: ✅. 

Finally, on innovation… 

AI isn’t a buzzword at Phreesia – it’s baked into the platform’s core. Co-founder and CEO Chaim Indig has been explicit: Artificial intelligence is already embedded across the system, automating workflows, personalizing patient outreach, and improving medication adherence. The company is attacking a $10 billion-plus addressable market, and it’s doing it with a deeply innovative AI-enabled platform that gets harder to displace with every passing month. Trigger five: ✅. 

Put it all together and Phreesia is a rare find: a profitable, recurring-revenue business with institutional-grade scale, an AI engine that’s only getting smarter, and a valuation that still hasn’t caught up to the opportunity. That won’t last. 

Recommendation: Buy Phreesia (NYSE: PHR) at market. Set a 25% trailing stop to protect your principal and your profits. 

Go With the Data: NIQ Global Intelligence 

A company you can always bet on is one that does something simple – and does it better than anyone else on Earth. That’s NIQ Global Intelligence (NYSE: NIQ) in a nutshell. 

NIQ is one of the most powerful – and least understood – data companies in the world. It tracks trillions of individual retail transactions across more than 90 countries, covering consumer packaged goods, grocery, e-commerce, and now real-time AI-driven demand forecasting. 

When brands like Coca-Cola, Nestlé, Procter & Gamble, Walmart, Amazon, and Target need to know what consumers are buying, where they’re buying it, how price changes affect demand, and what will sell next month – they turn to NIQ. No one else has this depth of data. No one else has this scale. 

What NIQ does is simple: it sells data and predictive insight. But the way it does it – by layering artificial intelligence over one of the largest consumer datasets on Earth – is anything but simple. That combination has pushed subscription revenue, enterprise contracts, and pricing power steadily higher.  

So it’s a true innovator and disruptor. And the financials prove it… 

Revenue Growth, Margins, and the Full Scorecard 

Starting with revenue growth… 

Over the past two years, NIQ has produced consistent double-digit revenue growth as a public company. Revenue moved from roughly $3.7 billion in 2023 to more than $4.1 billion in 2024, and through the first three quarters of 2025 was tracking in range of  $4.5 billion to $4.7 billion on a trailing-12-month basis. Year-over-year growth sits firmly in the 10% to 13% range, with recurring subscription revenue accounting for more than 80% of total sales. Trigger one: ✅. 

On EPS growth… 

NIQ has moved through its post-IPO investment and restructuring phase and is now entering a margin-expansion cycle. Through 2025, adjusted EBITDA margins moved into the high-20% range, free cash flow expanded meaningfully, and Wall Street expects double-digit adjusted EPS growth in 2026. Trigger two: ✅. 

On RSI… 

As of early December 2025, NIQ’s 14-day relative strength index has been fluctuating between the mid-50s and low 60s. That’s exactly what I want to see – strong momentum without being overbought. Trigger three: ✅. 

And the insiders agree… 

Since the IPO, senior executives and directors have made open-market purchases during periods of post-IPO volatility, while private-equity sponsors KKR and Advent remain major long-term shareholders. Crucially, there has been no pattern of aggressive insider selling – a clear signal that management and long-term sponsors are aligned with shareholders and expect the business to keep compounding. Trigger four: ✅. 

Put it all together and you have a winner. NIQ doesn’t depend on consumer fads, advertising cycles, or any single product. It monetizes data subscriptions, enterprise analytics, and predictive AI – the backbone of modern retail decision-making. As long as commerce exists, NIQ’s data will be in demand. 

Recommendation: Buy NIQ Global Intelligence (NYSE: NIQ) at market. Set a 25% trailing stop to protect your principal and your profits.

Millionaire’s Microcap Portfolio

The “frenzy phase” of this tech boom will be one of the greatest wealth-creation events since the 1990s. Microcap stocks like the three in this report will be the biggest wealth creators in that event.

Each one is trading for bargain-basement prices but has great financials, innovative products, and serious potential. They’re hidden champions in the making, set to flourish as soon as the myriad triggers in this market are pulled.

These are the stocks with the potential to be the next Google, Netflix, Amazon, or Nvidia… and, a few years from now, you’ll be glad you invested in them.

The recent phase of this boom has already minted 600,000 NEW millionaires. 

This final phase could be 2X, 3X, even 4X bigger. 

The question is, which side will you be on? 

Will you watch from the sidelines as this event creates the next wave of millionaires? Or will you be among the investors who spotted the next generation of tech giants before the rest of the world caught on? 

These are the stocks with the potential to become the next Google, Netflix, Amazon, or Nvidia… and a few years from now, you’ll be glad you acted.